Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 65862-784

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 65862-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Esomeprazole Fig1)

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Esomeprazole Fig2)

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)

This is a clinical trial result showing the percentage of patients who were symptom-free after using Esomeprazole Magnesium Delayed-Release Capsules 40 mg or 20 mg compared to those who took a placebo. The trial lasted for 21 days, and the symptom-free rate was 100% for both doses of the medication, while the placebo showed a lower percentage.*

FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)

This appears to be a graph but the data is not sufficient for generating a useful description.*

FDA Label Image

Package Label-principal Display Panel (20 mg (30 Capsules Bottle))

FDA Label Image

Package Label-principal Display Panel (20 MG (10 X 10) UNIT-DOSE CAPSULES)

Esomeprazole Magnesium Delayed-Release Capsules USP are a medication that each contain 20 mg of esomeprazole magnesium dihydrate. The capsules are intended for adult usage as directed on the package insert and must be stored at controlled room temperature between 20-25°C (68-77°F). The packaging is non-child resistant and is not safe for dispensing to patients who need child-proof containers. The medication guide is to be provided to each patient by their pharmacist. The capsules are distributed by Aurobindo Pharma in the USA and were manufactured in India.*

FDA Label Image

Package Label-principal Display Panel (40 MG (30 CAPSULES BOTTLE))

This is a prescription medicine with NDC number 65862-784-30. It contains Esomeprazole Magnesium in the form of Delayed-Release Capsules USP, equivalent to 40 mg of esomeprazole. The brand Aurobindo distributes the 30 capsules, and the medication guide should be provided to each patient. There is additional information regarding dosage recommendations and storage instructions. There is also a printed warning about a "Zone Coding Area" that should not be printed over.*

FDA Label Image

Package Label-principal Display Panel (40 MG (10 X 10) UNIT-DOSE CAPSULES)

This is a medication called Esomeprazole Magnesium which comes in 100 unit-dose capsules. Each capsule contains 40 mg of Esomeprazole magnesium dihydrate equivalent. The medication is for adult use only and the package insert should be consulted for proper dosage information. It should be stored at controlled room temperature between 20° to 25°C (68° to 77°F). The container must be tightly closed and is not child resistant. The medication guide should be provided separately to each patient. The capsules are distributed by Aurobindo Pharma USA, Inc. and made in India.*

FDA Label Image

Chemical Structure (Esomeprazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.